Prashant Sahu
Overview
Explore the profile of Prashant Sahu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
151
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rajput D, Singh M, Sahu P, Jain D, Kashaw S, Patil U
Mini Rev Med Chem
. 2023 Feb;
23(21):2053-2072.
PMID: 36809967
Nanogels have gotten much attention as nanoscopic drug carriers, especially for delivering bioactive mediators to specific sites or at certain times. The versatility of polymer systems and the ease with...
2.
Nair S, Sinha P, Chand P, Sahu P, Gorthi N, Varghese M, et al.
Front Psychiatry
. 2022 Jun;
13:869685.
PMID: 35677870
Objective: The study aimed to evaluate the effectiveness of a program based on the telementoring model [Extension for Community Healthcare Outcomes (ECHO)] for primary care physicians in diagnosing and treating...
3.
Begum S, Pratibha S, Rawat J, Venugopal D, Sahu P, Gowda A, et al.
Pharmaceuticals (Basel)
. 2022 Apr;
15(4).
PMID: 35455452
Nanoparticles (NPs) are elements derived from a cluster of atoms with one or more dimensions in the nanometer scale in the range of 1-100 nm. The bio nanofabrication of metallic...
4.
Sahu P, Thippeswamy H, Chaturvedi S
Vitam Horm
. 2022 Mar;
119:457-470.
PMID: 35337631
Vitamin B12 deficiency can have distressing neuropsychiatric symptoms. It can have an etiological role in clinical presentations like depression, anxiety, psychosis, dementia, and delirium, requiring screening of at-risk populations. Few...
5.
Sahu P, Kashaw S, Kashaw V, Shabaaz J, Dahiya R
Int J Biol Macromol
. 2021 Jul;
187:742-754.
PMID: 34310997
A surface modulated biodegradable transdermal strategy has been exploited for improving the biopharmaceutical properties of Temozolomide augmented in Poly Lactic-co-glycolic acid (PLGA) chitosan double walled nanogel (PCNGL). The PCNGL was...
6.
Acceptance of e-consult for Substance Use Disorders during the COVID 19 pandemic: A study from India
Sahu P, Mathur A, Ganesh A, Nair S, Chand P, Murthy P
Asian J Psychiatr
. 2020 Dec;
54:102451.
PMID: 33271730
Objectives: The COVID 19 pandemic has created challenges in providing timely care for patients and families with Substance Use disorders (SUDs). With the difficulties in face-to-face consultations because of social...
7.
Ganesh A, Sahu P, Nair S, Chand P
Asian J Psychiatr
. 2020 Apr;
51:102120.
PMID: 32344333
No abstract available.
8.
Kashaw S, Sahu P, Rajoriya V, Jana P, Kashaw V, Sau S, et al.
Curr Pharm Des
. 2020 Apr;
26(27):3234-3250.
PMID: 32303162
Potential short interfering RNAs (siRNA) modulating gene expression have emerged as a novel therapeutic arsenal against a wide range of maladies and disorders containing cancer, viral infections, bacterial ailments and...
9.
Sahu P, Kashaw S, Sau S, Kushwah V, Jain S, Iyer A
Mater Sci Eng C Mater Biol Appl
. 2019 Nov;
107:110263.
PMID: 31761163
A modified facile biomimetic Temozolomide Chitosan nanogel (TCNL) was developed offering pH responsive, charge attracted and microenvironment dependent tumor targeting nanotherapy. USFDA approved chemotherapeutic TMZ (Temozolomide) was encapsulated in a...
10.
Sahu P, Kashaw S, Sau S, Kushwah V, Jain S, Agrawal R, et al.
Int J Biol Macromol
. 2019 Jan;
128:740-751.
PMID: 30699336
The current research is focused to develop and investigate the toxicity and penetration potential of biocompatible chitosan nanogel encapsulating capecitabine by ionic interaction mechanism exhibiting pH triggered transdermal targeting. The...